Eyeworld

3 EW ASCRS NEWS July 2018 by Liz Hillman EyeWorld Senior Staff Writer the latest advances with critical evaluation and surgical pearls that can be applied immediately when attendees return to clinical practice. "Also, the number of attendees is small enough that everyone has access to the faculty to share cases, ask questions, etc.," Dr. Koch said. Dr. Garg also hailed the size of the meeting as a benefit, in addition to its "practical and up-to-date" agenda. "The intimate setting with great interaction among faculty and attendees is a highlight for all," he said. "I think that the attendees enjoy the honest, lively discussions about topics and cases, along with the casual setting," Dr. Cionni said, adding that the access and interac- tions with faculty make this meeting unique. "Unlike larger meetings, the faculty are there essentially all of the time, contributing as speakers, panelists, and participants in the audience," Dr. Koch said. Attendees of previous Surgical Summit meetings have said they "get more pearls out of this meeting every year than any other meeting I attend" and that it offers a "huge amount of practical and clinically applicable information." Eighty- four percent of those who provided feedback about the 2018 meeting said they expected to change their practice in response to education they received there. The meeting is organized in such a way that attendees can maximize educational content and interaction with exhibitors in addition to taking advantage of the area's extracurricular activities. After breakfast in the exhibit hall, pro- gramming begins at 7:00 a.m. and runs until just before noon when lunch will be served and attendees can break for an afternoon of skiing, Intimate meeting setting combines top-notch education with activities like skiing, Sundance Film Festival W hile snow and icy temperatures are prob- ably the last thing on your mind in the mid- dle of summer, now is actually the time to start thinking about the third annual Surgical Summit: Innovative Techniques and Controversies in Ophthalmology, taking place in Park City, Utah, Jan. 31–Feb. 2, 2019. Nestled in Deer Valley, a premier skiing and winter activities destina- tion, the Surgical Summit will co- incide with the Sundance Film Fes- tival, an internationally renowned event for independent films. In 2018, more than 110 attend- ees from 29 states (and even a few international countries) and more than a dozen exhibitors attended the Surgical Summit, which is spon- sored by EyeWorld and the Ameri- can Society of Cataract and Refrac- tive Surgery. Douglas Koch, MD, Houston, co-chair of the Surgical Summit, along with Robert Cionni, MD, Salt Lake City, and Sumit "Sam" Garg, MD, Irvine, California, said he expects this year's Surgical Summit to reach similarly high attendance. Because of that, along with its proximity to the Sundance Film Festival, the program chairs are encouraging interested attendees to register early. "We expect a capacity atten- dance, so we recommend registering early," Dr. Koch said, adding that this year's faculty will include an "all-star group of speakers who are wonderful educators." Dr. Koch expounded upon edu- cational programing at the Surgical Summit, which he said emphasizes Gear up for the 2019 Surgical Summit continued on page 8 " The intimate setting with great interaction among faculty and attendees is a highlight for all. " —Sumit "Sam" Garg, MD © 2018 Novartis 3/18 US-ORA-18-E-0463a ORA SYSTEM ® Technology - IMPORTANT PRODUCT INFORMATION CAUTION: Federal (USA) law restricts this device to the sale by or on the order of a physician. INDICATIONS: Federal (USA) law restricts this device to sale by, or on the order of, a physician. INTENDED USE: The ORA SYSTEM ® technology utilizes wavefront aberrometry data to measure and analyze the refractive power of the eye (i.e. sphere, cylinder, and axis measurements) to support cataract surgical procedures. WARNINGS AND PRECAUTIONS: The following conditions may make it difficult to obtain accurate readings using the ORA SYSTEM ® technology: • Patients having progressive retinal pathology such as diabetic retinopathy, macular degeneration, or any other pathology that the physician deems would interfere with patient fixation; • Patients having corneal pathology such as Fuchs', EBMD, keratoconus, advanced pterygium impairing the cornea, or any other pathology that the physician deems would interfere with the measurement process; • Patients for which the preoperative regimen includes residual viscous substances left on the corneal surface such as lidocaine gel or viscoelastics; • Visually significant media opacity, such as prominent floaters or asteroid hyalosis, will either limit or prohibit the measurement process; or • Patients having received retro or peribulbar block or any other treatment that impairs their ability to visualize the fixation light. • Use of iris hooks during an ORA SYSTEM ® technology image capture will yield inaccurate measurements. In addition: • Significant central corneal irregularities resulting in higher order aberrations might yield inaccurate refractive measurements. • Post refractive keratectomy eyes might yield inaccurate refractive measurement. • The safety and effectiveness of using the data from the ORA SYSTEM ® have not been established for determining treatments involving higher order aberrations of the eye such as coma and spherical aberrations. • ORA SYSTEM ® technology is intended for use by qualified health personnel only. • Improper use of this device may result in exposure to dangerous voltage or hazardous laser-like radiation exposure. DO NOT OPERATE the ORA SYSTEM ® in the presence of flammable anesthetics or volatile solvents such as alcohol or benzene, or in locations that present an explosion hazard. ATTENTION: Refer to the ORA SYSTEM ® Operator's Manual for a complete description of proper use and maintenance, as well as a complete list of contraindications, warnings and precautions. 102088 US-ORA-18-E-0463a_PI EW.indd 1 6/12/18 10:34 AM Robert Cionni, MD Sumit (Sam) Garg, MD Douglas Koch, MD 2 0 1 9 P R O G R A M C H A I R S

• Blank Page
• Blank Page (1)